Physician

Sarah Minka, DO

According to 2025 Medicare claims, Sarah Minka, DO (NPI: 1467872002) practices dermatology in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is DEFINE DERMATOLOGY PLLC (NPI: 1609576404; TIN: 922759764) and primary practice location at 76310-2303.

Minka's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 208 traditional Medicare patients, billed 2,407 HCPCS/CPT codes, and received $40,409 in Medicare payments. 2024 Part D data shows 11 prescription claims totaling $26,622 in drug costs. 2019 DME data shows 12 claims. Open Payments data shows 16 records totaling $253. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $5,439 to $40,409. Similarly, Part D prescription costs have fallen sharply in recent years, from $5,998 to $26,622. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$140K$280K2017 Medicare payment: $5,439 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $69,687 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $280,400 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $233,727 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $123,601 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $31,597 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $40,409 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172471$5,439
20182651,052$69,687
20195614,279$280,400
20206073,263$233,727
20214161,896$123,601
20221172,404$31,597
20232082,407$40,409
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$244K$488K2015 Drug cost: $5,998 (USD; Tot_Drug_Cst)2016 Drug cost: $28,724 (USD; Tot_Drug_Cst)2017 Drug cost: $50,264 (USD; Tot_Drug_Cst)2018 Drug cost: $487,827 (USD; Tot_Drug_Cst)2019 Drug cost: $276,163 (USD; Tot_Drug_Cst)2020 Drug cost: $301,584 (USD; Tot_Drug_Cst)2021 Drug cost: $186,813 (USD; Tot_Drug_Cst)2022 Drug cost: $7,927 (USD; Tot_Drug_Cst)2023 Drug cost: $130,077 (USD; Tot_Drug_Cst)2024 Drug cost: $26,622 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201580141$5,998
2016179380$28,724
2017118218$50,264
2018242740$487,827
2019277723$276,163
2020155357$301,584
2021113214$186,813
2022114175$7,927
2023123252$130,077
2024N/R11$26,622

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$156K$312K2016 Medicare payment: $9,917 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $30,432 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $311,519 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $10,219 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R12$9,917
20172234$30,432
2018447461$311,519
2019N/R12$10,219
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$253Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah Minka, DO?

Tedicare shows public-source Medicare data for Sarah Minka, DO (NPI 1467872002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Minka, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah Minka, DO?

Sarah Minka, DO is linked to DEFINE DERMATOLOGY PLLC (billing NPI 1609576404) in the available physician profile data.

Does Sarah Minka, DO have Open Payments data?

Sarah Minka, DO has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.